Pharmaceuticals & Life Sciences · Commercial & Market Access
Market Access & Payer Strategy
Trajectories describe the observable direction of human effort — not a prediction about specific roles, headcount, or individual careers.
What You Do Today
Develop pricing and market access strategies — negotiate with PBMs, health plans, and hospital systems for formulary placement. Build HEOR (health economics and outcomes research) evidence packages, manage rebate contracts, and design patient access programs that reduce out-of-pocket costs.
AI Technologies
Roles Involved
How It Works
ML models optimize pricing by simulating payer response across different price points, rebate structures, and outcomes-based contract terms. AI synthesizes real-world evidence to build value dossiers that demonstrate economic value to payers. Contract modeling predicts the net revenue impact of different rebate scenarios.
What Changes
Pricing strategy becomes more data-driven as AI models predict payer behavior and formulary decisions under different scenarios. Value story development accelerates with automated evidence synthesis.
What Stays the Same
Negotiating with PBMs, building relationships with medical directors at health plans, and making the strategic trade-offs between price, access, and volume require human judgment and negotiation skills.
Cross-Industry Concepts
Evidence & Sources
- •AMCP dossier submission standards
- •ISPOR value assessment frameworks
Sources listed are directional references, not formal citations. Verify against primary sources before using in business cases or presentations.
Last reviewed: March 2026
What To Do Next
This section won't tell you what your numbers should be. It will show you how to find them yourself. Every instruction below produces a real, verifiable result in your organization. No benchmarks, no projections — just the steps to build your own evidence.
Establish Your Baseline
Know where you are before you move
Before adopting AI tools for market access & payer strategy, document your current state in commercial & market access.
Without a baseline, you can't tell whether AI actually improved market access & payer strategy or just changed who does it.
Define Your Measures
What to track and how to calculate it
campaign ROI
How to calculate
Measure campaign ROI for market access & payer strategy before and after AI adoption. Pull from your marketing automation platform.
Why it matters
This is the most direct indicator of whether AI is adding value to commercial & market access.
marketing qualified leads
How to calculate
Track marketing qualified leads using the same methodology you use today. Don't change how you measure just because you changed how you work.
Why it matters
Speed without quality is just faster mistakes. Measure both together.
Start These Conversations
Who to talk to and what to ask
CMO or VP Marketing
“What's our plan for AI in commercial & market access? Are we piloting, planning, or waiting?”
This tells you whether to experiment quietly or push for formal investment in market access & payer strategy.
your marketing automation platform administrator or vendor
“What AI capabilities exist in our current marketing automation platform that we're not using? Most platforms are adding AI features faster than teams adopt them.”
The cheapest AI adoption is the features already included in your existing license.
a practitioner in commercial & market access at another organization
“Have you deployed AI for market access & payer strategy? What worked, what didn't, and what would you do differently?”
Peer experience is more useful than vendor demos. Find someone who has actually done this.
Check Your Prerequisites
Confirm readiness before you invest
Check items as you confirm them.